A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression-Reference-Cited by-同舟云学术

A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression

Published:2017-05 Issue:3 Volume:19 Page:198-213
ISSN:1398-5647
Container-title:Bipolar Disorders
language:en
Short-container-title:Bipolar Disord

Author:

Soczynska Joanna K¹²^ORCID,Kennedy Sidney H¹²³,Alsuwaidan Mohammad³⁴,Mansur Rodrigo B²,Li Madeline³⁵,McAndrews Mary Pat⁶⁷,Brietzke Elisa⁸,Woldeyohannes Hanna O²,Taylor Valerie H³⁹,McIntyre Roger S¹²³¹⁰^ORCID

Affiliation:

1. Institute of Medical Science; University of Toronto; Toronto ON Canada

2. Mood Disorders Psychopharmacology Unit; University Health Network; Toronto ON Canada

3. Department of Psychiatry; University of Toronto; Toronto ON Canada

4. Department of Psychiatry; Kuwait University; Kuwait City Kuwait

5. Psychosocial Oncology Clinic; University Health Network; Toronto ON Canada

6. Department of Psychology; University of Toronto; Toronto ON Canada

7. Neuropsychology Clinic; University Health Network; Toronto ON Canada

8. Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder; Department of Psychiatry; Federal University of São Paulo; São Paulo Brazil

9. Department of Psychiatry; Women's College Hospital; Toronto ON Canada

10. Department of Toxicology and Pharmacology; University of Toronto; Toronto ON Canada

Funder

Mood Disorders Psychopharmacology Unit (MDPU)

Canadian Biomarker Integration Network for Depression (CAN-BIND)

Beijing Cultural Development Foundation

Eli Lilly Canada Fellowship

Ontario Graduate Scholarship

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health